Bridgeway Capital Management’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-120,785
Closed -$3.05M 1500
2017
Q1
$3.05M Sell
120,785
-35,400
-23% -$727K 0.04% 410
2016
Q4
$2.03M Hold
156,185
0.03% 568
2016
Q3
$748K Hold
156,185
0.01% 916
2016
Q2
$592K Buy
156,185
+18,235
+13% +$63.4K 0.01% 969
2016
Q1
$381K Hold
137,950
0.01% 1143
2015
Q4
$792K Buy
137,950
+28,550
+26% +$164K 0.01% 861
2015
Q3
$630K Buy
109,400
+11,371
+12% +$77.5K 0.01% 929
2015
Q2
$591K Buy
98,029
+28,629
+41% +$178K 0.01% 994
2015
Q1
$677K Buy
69,400
+54,400
+363% +$613K 0.01% 960
2014
Q4
$196K Hold
15,000
﹤0.01% 1308
2014
Q3
$134K Buy
+15,000
New +$154K ﹤0.01% 1387

Other funds holding AKAO

Bridgeway Capital Management's AKAO Position: Q2 2017 in Review

Bridgeway Capital Management sold out of Achaogen Inc (AKAO) in Q2 2017, closing a stake of 120,785 shares — an estimated $3.05M sold.

Bridgeway Capital Management first reported a position in AKAO in Q3 2014 and held it in 11 quarters. The position peaked at $3.05M in Q1 2017. 106 funds tracked by Wall St. Rank hold AKAO as of Q2 2017.

  • Bridgeway Capital Management reported no remaining Achaogen Inc position as of Q2 2017 after selling out during the quarter.
  • Bridgeway Capital Management sold 120,785 Achaogen Inc shares in Q2 2017, an estimated $3.05M.
  • Bridgeway Capital Management first reported a position in Achaogen Inc in Q3 2014 and held it in 11 quarters.
  • Bridgeway Capital Management's Achaogen Inc position peaked at $3.05M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2017.

Based on Bridgeway Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.